TRIM33 and dermatomyositis: A recent study revealed that some serum inflammatory cytokines, including the B-cell activating factor of the TNF superfamily (BAFF), soluble TNF receptor 1 (sTNF-R1), and sTNF-R2 could be cancer predictors among anti-TIF1-γ antibody-positive DM patients [16].